XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2023 $ 74,272 $ 5 $ 25 $ 500,752 $ (12,969) $ (414,870) $ 1,329
Beginning Balances (in shares) at Dec. 31, 2023   5,000 23,247        
Net loss (4,558)         (4,558)  
Unrealized income (loss) from foreign currency translation adjustments (290)           (290)
Issuance of common stock in connection with vesting of stock awards (shares)     120        
Stock-based compensation 1,019     1,019      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (277)       (277)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (33)        
Ending Balances at Mar. 31, 2024 70,166 $ 5 $ 25 501,771 (13,246) (419,428) 1,039
Ending Balances (in shares) at Mar. 31, 2024   5,000 23,334        
Beginning Balances at Dec. 31, 2024 154,069 $ 5 $ 26 509,482 (16,490) (340,050) 1,096
Beginning Balances (in shares) at Dec. 31, 2024   5,000 23,431        
Net loss (4,789)         (4,789)  
Unrealized income (loss) from foreign currency translation adjustments 592           592
Issuance of common stock in connection with vesting of stock awards (shares)     138        
Stock-based compensation 796     796      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (169)       (169)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (48)        
Ending Balances at Mar. 31, 2025 $ 150,499 $ 5 $ 26 $ 510,278 $ (16,659) $ (344,839) $ 1,688
Ending Balances (in shares) at Mar. 31, 2025   5,000 23,521